Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (Q27860650)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 11 July 2013)
edit
Language Label Description Also known as
English
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
scientific article (publication date: 11 July 2013)

    Statements

    Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Omid Hamid
    0 references
    Wen-Jen Hwu
    0 references
    Peter Hersey
    0 references
    Jeffrey S Weber
    0 references
    Amita Patnaik
    0 references
    Hassane Zarour
    0 references
    Kevin Gergich
    0 references
    Jeroen Elassaiss-Schaap
    0 references
    Alain Algazi
    0 references
    Christine Mateus
    0 references
    Peter Boasberg
    0 references
    Paul C Tumeh
    0 references
    Scot W Ebbinghaus
    0 references
    Xiaoyun Nicole Li
    0 references
    S Peter Kang
    0 references
    11 July 2013
    0 references
    369
    0 references
    134-44
    0 references
    2
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit